Identification of B-cell-related HSPG2 and CDSN as susceptibility loci for Kawasaki disease

被引:0
|
作者
Kim, Jae-Jung [1 ]
Hong, Young Mi [2 ]
Yun, Sin Weon [3 ]
Lee, Kyung-Yil [4 ]
Yoon, Kyung Lim [5 ]
Han, Myung-Ki [6 ]
Kim, Gi Beom [7 ]
Kil, Hong-Ryang [8 ]
Song, Min Seob [9 ]
Lee, Hyoung Doo [10 ]
Ha, Kee Soo [11 ]
Jun, Hyun Ok [12 ]
Yu, Jeong Jin [13 ]
Jang, Gi Young
Lee, Jong-Keuk [1 ]
机构
[1] Univ Ulsan, Asan Inst Life Sci, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea
[2] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea
[3] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea
[4] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Pediat, Daejeon, South Korea
[5] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea
[6] Univ Ulsan, Gangneung Asan Hosp, Dept Pediat, Kangnung, South Korea
[7] Seoul Natl Univ, Dept Pediat, Childrens Hosp, Seoul, South Korea
[8] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea
[9] Inje Univ, Dept Pediat, Paik Hosp, Busan, South Korea
[10] Pusan Natl Univ Hosp, Dept Pediat, Busan, South Korea
[11] Korea Univ Hosp, Dept Pediat, Seoul, South Korea
[12] Yonsei Univ, Severance Cardiovasc Hosp, Dept Cardiovasc Surg, Coll Med, Seoul, South Korea
[13] Univ Ulsan, Dept Pediat, Asan Med Ctr, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Kawasaki disease; Susceptibility; Association study; B-cell-related genes; GENOME-WIDE ASSOCIATION;
D O I
10.1016/j.humimm.2023.07.001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Kawasaki disease (KD) is an acute pediatric vasculitis that predominantly affects children under the age of 5 years. To date, genome-wide association studies (GWAS) have identified several KD susceptibility genes (e.g., BLK, CD40, FCGR2A, BCL2L11, and IGHV), which are mainly involved in B cell immunity. In this study, we aimed to identify additional KD susceptibility genes mainly involved in B cell development and functions by analyzing our previous GWAS data and conducting a replication study using new sample. Initially, we selected 30 single nucleotide polymorphisms (SNPs) in B-cell-related genes that were significantly (P < 0.01) associated with KD in our previous GWAS analysis of 247 KD cases with complete type and 1,000 healthy controls. Replication study was performed by genotyping the new 837 KD case samples with Fluidigm system and comparing them with 3,553 control genotypes. Among the 30 candidate SNPs, two were significantly associated with KD (P 0.001) in the replication study. An even greater association between these SNPs and KD was observed in the combined analysis of GWAS and replication samples: odds ratio (OR) = 1.97 (P = 8.61 x 10-6) for rs2270699 (nonsynonymous SNP: c.10588C T, p.Arg3530Trp) in the heparan sulfate proteoglycan 2 (HSPG2) gene and OR = 1.28 (P = 1.34 x 10-6) for rs3130992 (intronic SNP) in both the corneodesmosin (CDSN) and psoriasis susceptibility 1 candidate 1 (PSORS1C1) genes. These results suggest that the B-cell related genes, HSPG2 and CDSN or PSORS1C1, play a role in the development of KD.
引用
收藏
页码:567 / 570
页数:4
相关论文
共 44 条
  • [21] The role of the blood group-related glycosyltransferases FUT2 and B4GALNT2 in susceptibility to infectious disease
    Galeev, Alibek
    Suwandi, Abdulhadi
    Cepic, Aleksa
    Basu, Meghna
    Baines, John F.
    Grassl, Guntram A.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2021, 311 (03)
  • [22] Microarray analysis of gene-expression profiles in diffuse large B-cell lymphoma: Identification of genes related to disease progression
    Nishiu, M
    Yanagawa, R
    Nakatsuka, S
    Yao, M
    Tsunoda, T
    Nakamura, Y
    Aozasa, K
    JAPANESE JOURNAL OF CANCER RESEARCH, 2002, 93 (08): : 894 - 901
  • [23] Human lymphocyte antigen B-associated transcript 2, 3, and 5 polymorphisms and haplotypes are associated with susceptibility of Kawasaki disease and coronary artery aneurysm (vol 24, pg 262, 2010)
    Hsieh, Yao-Yuan
    Lin, Ying-Ju
    Chang, Chi-Chen
    Chen, Da-Yuan
    Hsu, Chin-Mu
    Wang, Yu-Kuo
    Hsu, Kung-Hao
    Tsai, Fuu-Jen
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2011, 25 (01) : 64 - 64
  • [24] The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Faslpr mice
    Xu, Z.
    Croker, B. P.
    Morel, L.
    GENES AND IMMUNITY, 2013, 14 (06) : 373 - 379
  • [25] The combination of two Sle2 lupus-susceptibility loci and Cdkn2c deficiency leads to T-cell-mediated pathology in B6.Faslpr mice
    Z Xu
    B P Croker
    L Morel
    Genes & Immunity, 2013, 14 : 373 - 379
  • [26] B cell epitopes of the heterogeneous nuclear ribonucleoprotein A2: identification of a new specific antibody marker for active lupus disease
    Schett, G.
    Dumortier, H.
    Hoefler, E.
    Muller, S.
    Steiner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 729 - 735
  • [27] RELATIONSHIP BETWEEN HUMAN LEUKOCYTE ANTIGEN (HLA)-A/-B LOCI COMBINATIONS AND LESIONS OF BEHCET'S DISEASE. A COMBINATION OF HLA-A2/B51 IS RELATED TO GENITAL LESIONS IN JAPAN
    Kobashigawa, Tsuyoshi
    Nanke, Yuki
    Inoue, Eisaku
    Ichikawa, Naomi
    Furuya, Takefumi
    Kamatani, Naoyuki
    Kotake, Shigeru
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (04) : S10 - S11
  • [28] INTERIM RESULTS OF A PHASE 2 STUDY OF XMAB®5871, A REVERSIBLE B CELL INHIBITOR, IN IGG4-RELATED DISEASE
    Stone, J. H.
    Wallace, Z. S.
    Perugino, C. A.
    Fernandes, A. D.
    Patel, P. S.
    Foster, P. A.
    Zack, D. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 711 - 712
  • [29] T-CELL-RICH B-CELL LYMPHOMA AND LYMPHOCYTE-PREDOMINANT HODGKINS-DISEASE - 2 CLOSELY-RELATED ENTITIES
    SCHMIDT, U
    METZ, KA
    LEDER, LD
    BRITISH JOURNAL OF HAEMATOLOGY, 1995, 90 (02) : 398 - 403
  • [30] Identification of antigen-presentation related B cells as a key player in Crohn’s disease using single-cell dissecting, hdWGCNA, and deep learning
    Xin Shen
    Shaocong Mo
    Xinlei Zeng
    Yulin Wang
    Lingxi Lin
    Meilin Weng
    Takehito Sugasawa
    Lei Wang
    Wenchao Gu
    Takahito Nakajima
    Clinical and Experimental Medicine, 2023, 23 : 5255 - 5267